Clinical Trial Update: Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 [Phase 2]

View source ↗

Summary

Phase 2 long-term follow-up study assessing safety and maintenance of efficacy of ATX-101 for submental fat shows completed results with data posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Submental Fat

Drugs mentioned

• ATX-101 (Deoxycholic acid)

Snippet

Sponsor: Kythera Biopharmaceuticals | Conditions: Submental Fat, Healthy | Phase 2 | Status: COMPLETED | Results posted: 2020-02-17